statistiche ricercatore

VISCA, DINA

Distribuzione geografica

Continente	#
NA - Nord America	6.720
EU - Europa	2.913
AS - Asia	2.720
SA - Sud America	378
AF - Africa	84
OC - Oceania	13
Continente sconosciuto - Info sul continente non disponibili	6
Totale	12.834

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	6.617
IT - Italia	1.489
SG - Singapore	1.072
CN - Cina	543
HK - Hong Kong	422
VN - Vietnam	402
BR - Brasile	305
UA - Ucraina	286
IE - Irlanda	195
DE - Germania	177
SE - Svezia	156
GB - Regno Unito	147
FR - Francia	130
RU - Federazione Russa	105
TR - Turchia	81
FI - Finlandia	65
MX - Messico	54
AT - Austria	49
CA - Canada	40
AR - Argentina	33
JP - Giappone	31
IN - India	30
BD - Bangladesh	27
NG - Nigeria	27
IQ - Iraq	23
ZA - Sudafrica	23
ES - Italia	22
NL - Olanda	19
PL - Polonia	17
CL - Cile	14
ID - Indonesia	13
PK - Pakistan	13
AU - Australia	12
CZ - Repubblica Ceca	12
SA - Arabia Saudita	9
IR - Iran	7
LT - Lituania	7
RO - Romania	7
EC - Ecuador	6
MY - Malesia	6
AE - Emirati Arabi Uniti	5
EG - Egitto	5
EU - Europa	5
PH - Filippine	5
SK - Slovacchia (Repubblica Slovacca)	5
VE - Venezuela	5
JO - Giordania	4
KE - Kenya	4
KZ - Kazakistan	4
MA - Marocco	4
OM - Oman	4
PT - Portogallo	4
PY - Paraguay	4
UY - Uruguay	4
AL - Albania	3
BE - Belgio	3
DZ - Algeria	3
HU - Ungheria	3
MD - Moldavia	3
PE - Perù	3
SN - Senegal	3
TN - Tunisia	3
UZ - Uzbekistan	3
AZ - Azerbaigian	2
BH - Bahrain	2
BO - Bolivia	2
CH - Svizzera	2
CO - Colombia	2
DK - Danimarca	2
GN - Guinea	2
HN - Honduras	2
KH - Cambogia	2
LK - Sri Lanka	2
ZM - Zambia	2
A2 - ???statistics.table.value.countryCode.A2???	1
AM - Armenia	1
BN - Brunei Darussalam	1
BY - Bielorussia	1
CI - Costa d'Avorio	1
CR - Costa Rica	1
CU - Cuba	1
CY - Cipro	1
ET - Etiopia	1
GA - Gabon	1
GD - Grenada	1
GE - Georgia	1
GR - Grecia	1
JM - Giamaica	1
KG - Kirghizistan	1
LY - Libia	1
ML - Mali	1
MU - Mauritius	1
MZ - Mozambico	1
NO - Norvegia	1
NP - Nepal	1
NZ - Nuova Zelanda	1
PA - Panama	1
PS - Palestinian Territory	1
QA - Qatar	1
RS - Serbia	1
Totale	12.830

Salva come PNG Salva come JPEG

Città	#
Milan	1.017
Fairfield	746
Ashburn	664
Singapore	578
San Jose	534
Hong Kong	419
Woodbridge	351
Chandler	337
Houston	308
Seattle	286
Wilmington	286
Cambridge	279
Jacksonville	270
Dallas	198
Beijing	189
Dublin	189
Princeton	182
The Dalles	164
Ann Arbor	134
Chicago	123
Boardman	122
Lauterbourg	112
New York	110
Nyköping	99
Dearborn	93
Rome	91
Dong Ket	89
Ho Chi Minh City	86
Council Bluffs	78
Los Angeles	78
San Diego	77
London	67
Izmir	62
Helsinki	51
Hanoi	50
Ogden	45
Munich	44
Mexico City	40
São Paulo	39
Santa Clara	38
Nuremberg	30
Vienna	30
Abuja	27
Salt Lake City	25
Tokyo	25
Frankfurt am Main	22
San Francisco	22
Orem	21
Redmond	21
San Genesio Ed Uniti	19
Washington	19
Como	17
Guangzhou	15
Phoenix	15
Brooklyn	14
Norwalk	14
Tampa	14
Warsaw	14
Atlanta	13
Haiphong	13
Montreal	13
Elk Grove Village	12
Hangzhou	12
Hefei	12
Shanghai	12
Toronto	12
Belo Horizonte	11
Brno	11
Buffalo	11
Chennai	11
Johannesburg	11
Kunming	11
Varese	11
Baghdad	10
Pavia	9
Stockholm	9
Cedar Knolls	8
Dhaka	8
Kilburn	8
Magnago	8
Rio de Janeiro	8
Biên Hòa	7
Denver	7
Falkenstein	7
Manchester	7
Amsterdam	6
Boston	6
Cape Town	6
Da Nang	6
Jakarta	6
Lancaster	6
Lappeenranta	6
Miami	6
Redwood City	6
Cavaria con Premezzo	5
Charlotte	5
Chiswick	5
Hải Dương	5
Kansas City	5
Mumbai	5
Totale	9.445

Salva come PNG Salva come JPEG

Nome	#
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases	329
Adverse Reactions to Food: Allergies and Intolerances	257
Classifying new anti-tuberculosis drugs: rationale and future perspectives	244
Adherence to Continuous Positive Airway Pressure in patients with Obstructive Sleep Apnoea. A ten year real life study	227
Airway inflammatory phenotypes: Making sputum cell evaluation more accessible for clinical use	211
Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae	192
When kidneys and lungs suffer together	189
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial	175
Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients	174
Cardiovascular function in pulmonary emphysema	172
Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial	168
Intestine: Organ or Apparatus?	168
Is bronchodilator the correct treatment for COPD subjects before EBUS?	167
Classification of Malabsorption Syndromes	166
Ambulatory oxygen in interstitial lung disease	164
Tuberculosis elimination: Where are we now?	162
Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation.	162
Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD	159
Effectiveness of pulmonary rehabilitation in severe asthma: a retrospective data analysis	158
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases	153
Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery	153
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis	151
Relationship between diabetes and respiratory diseases—Clinical and therapeutic aspects	151
Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: A systematic review	150
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: a global feasibility study	150
Ventilatory response to carbon dioxide output in subjects with congestive heart failure and in patients with COPD with comparable exercise capacity	149
Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns	145
Inhalation therapy devices for the treatment of obstructive lung diseases: the history of inhalers towards the ideal inhaler	144
New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis	142
Care-Related intervention in Rehabilitative Pneumology: Pulmonary Rehabilitation in Chronic Obstructive Broncopneumopathies (COPD) can benefit from a multidisciplinary approach? [Cure correlate in Pneumologia Riabilitativa: La Riabilitazione Polmonare nelle Broncopneumopatie Croniche Ostruttive (BPCO) può trarre beneficio da un approccio multidisciplinare?]	139
Eligibility for the shorter regimen for multidrug-resistant tuberculosis in Mexico	139
Electrocardiographic features of patients with COVID-19 pneumonia	138
Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine	138
Evolution of programmatic definitions used intuberculosis prevention and care	135
World TB Day 2017: Strengthening the fight against TB	134
Fecal calprotectin concentrations in alcoholic patients	133
Is Two Better Than One? The Impact of Doubling Training Volume in Severe COPD: A Randomized Controlled Study	133
Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night	132
The 5-repetition sit-to-stand test as an outcome measure for pulmonary rehabilitation in subjects with asthma	132
A snapshot of exhaled nitric oxide and asthma characteristics: experience from high to low income countries	130
Minimal clinically important difference of the 6-min walking test in patients with asthma	130
Pulmonary Rehabilitation and Asthma	125
The role of blood gas analysis in the post-acute phase of COVID-19 pneumonia	125
Multi and extensively drug-resistant pulmonary tuberculosis: Advances in diagnosis and management	124
Functional impairment during post-acute COVID-19 phase: Preliminary finding in 56 patients	118
Mepolizumab Improves Outcomes of Chronic Rhinosinusitis with Nasal Polyps in Severe Asthmatic Patients: A Multicentric Real-Life Study	117
Combined use of electrocardiography and ultrasound to detect cardiac and pulmonary involvement after recovery from COVID-19 pneumonia: A case series	115
Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts	113
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network	111
Time course of exercise capacity in patients recovering from COVID-19-associated pneumonia. Authors' reply	111
Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations	108
Severity of COVID-19: The importance of being hypertensive	105
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact	105
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: First global report	103
Effectiveness of a Pulmonary Rehabilitation Program on Persistent Asthma Stratified for Severity	102
Analysis of Patients with Asthma and Mixed Granulocytic Inflammatory Pattern in Sputum	101
Chronic cough in adults	100
Pulmonary rehabilitation in patients recovering from COVID-19	97
Something is changing in adherence to CPAP therapy: Real world data after 1 year of treatment in patients with obstructive sleep apnoea	96
Tuberculosis and COVID-19 co-infection: description of the global cohort	96
Effects of biological therapies on chronic rhinosinusitis in severe asthmatic patients	95
Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression	94
SARS-CoV-2 vaccines: Lights and shadows	94
Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects	91
Cost-effectiveness of ambulatory oxygen in improving quality of life in fibrotic lung disease: Preliminary evidence from the AmbOx Trial	89
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment	89
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort	88
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease	87
Post tuberculosis treatment infectious complications	86
Post-TB disease: a new topic for investigation-and why it matters	86
Pulmonary rehabilitation: Promising nonpharmacological approach for treating asthma?	85
Pulmonary rehabilitation in patients with interstitial lung diseases: Correlates of success	85
Joint effect of heart failure and coronary artery disease on the risk of death during hospitalization for COVID-19	85
Severe asthma: One disease and multiple definitions	84
Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry	82
Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial	80
Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)	78
High-flow oxygen therapy during exercise training in patients with chronic obstructive pulmonary disease and chronic hypoxemia: A multicenter randomized controlled trial	78
Rehabilitation, optimized nutritional care, and boosting host internal milieu to improve long-term treatment outcomes in tuberculosis patients	77
Time course of exercise capacity in patients recovering from covid-19-associated pneumonia	77
Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease	76
Alpha-1 deficiency in severe asthma patients	75
Epidemic and pandemic viral infections: Impact on tuberculosis and the lung	75
A systematic review of the costs of diagnosis for multidrug-resistant/extensively drug-resistant TB in different settings	74
Defining genetic risk factors for scleroderma-associated interstitial lung disease: IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease	74
History of prevention, diagnosis, treatment and rehabilitation of pulmonary sequelae of tuberculosis	73
Post-tuberculosis lung disease: a comparison of Brazilian, Italian, and Mexican cohorts	73
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy	73
Brazilian Thoracic Association recommendations for the management of post-tuberculosis lung disease	71
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment	70
An overview of Cochrane systematic reviews for pulmonary rehabilitation interventions in people with chronic obstructive pulmonary disease: a mapping synthesis	68
Correction to: When kidneys and lungs suffer together (Journal of Nephrology, (2019), 32, 5, (699-707), 10.1007/s40620-018-00563-1)	68
Tuberculosis in the time of COVID-19: quality of life and digital innovation	67
Management of chronic refractory cough in adults	67
Current developments and future directions in COPD	66
The Maugeri daily activity profile: A tool to assess physical activity in patients with chronic obstructive pulmonary disease	66
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life	65
Heart rate recovery in adult individuals with asthma	62
Post-tuberculosis sequelae: The need to look beyond treatment Outcome	61
Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence	60
Totale	11.911

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	66.736
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	66.736

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	618	0	0	0	0	0	0	0	0	0	132	195	291
2021/2022	970	147	27	64	11	33	63	85	72	58	244	69	97
2022/2023	1.055	102	82	104	132	58	227	6	109	133	49	21	32
2023/2024	1.808	248	259	245	301	374	154	72	18	75	39	6	17
2024/2025	1.880	20	25	281	50	74	140	67	76	237	275	176	459
2025/2026	3.861	314	272	247	485	312	221	1.020	288	495	207	0	0
Totale													13.189